127 related articles for article (PubMed ID: 22253232)
1. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.
Jeon BN; Kim MK; Choi WI; Koh DI; Hong SY; Kim KS; Kim M; Yun CO; Yoon J; Choi KY; Lee KR; Nephew KP; Hur MW
Cancer Res; 2012 Mar; 72(5):1137-48. PubMed ID: 22253232
[TBL] [Abstract][Full Text] [Related]
2. The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.
Lee KM; Choi WI; Koh DI; Kim YJ; Jeon BN; Yoon JH; Lee CE; Kim SH; Oh J; Hur MW
Oncogene; 2012 Mar; 31(11):1442-58. PubMed ID: 21804610
[TBL] [Abstract][Full Text] [Related]
3. Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter.
Jeon BN; Kim YS; Choi WI; Koh DI; Kim MK; Yoon JH; Kim MY; Hur B; Paik PD; Hur MW
J Lipid Res; 2012 Apr; 53(4):755-66. PubMed ID: 22331133
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.
Kim MK; Jeon BN; Koh DI; Kim KS; Park SY; Yun CO; Hur MW
J Biol Chem; 2013 Mar; 288(10):7053-64. PubMed ID: 23329847
[TBL] [Abstract][Full Text] [Related]
5. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.
Koh DI; Choi WI; Jeon BN; Lee CE; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(30):19856-66. PubMed ID: 19491398
[TBL] [Abstract][Full Text] [Related]
6. Kr-POK (ZBTB7c) regulates cancer cell proliferation through glutamine metabolism.
Hur MW; Yoon JH; Kim MY; Ko H; Jeon BN
Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):829-838. PubMed ID: 28571744
[TBL] [Abstract][Full Text] [Related]
7. Pierce1, a novel p53 target gene contributing to the ultraviolet-induced DNA damage response.
Sung YH; Kim HJ; Devkota S; Roh J; Lee J; Rhee K; Bahk YY; Lee HW
Cancer Res; 2010 Dec; 70(24):10454-63. PubMed ID: 21159655
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
10. Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene repression.
Choi WI; Kim MY; Jeon BN; Koh DI; Yun CO; Li Y; Lee CE; Oh J; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18625-40. PubMed ID: 24821727
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract][Full Text] [Related]
12. ZBTB2, a novel master regulator of the p53 pathway.
Jeon BN; Choi WI; Yu MY; Yoon AR; Kim MH; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(27):17935-46. PubMed ID: 19380588
[TBL] [Abstract][Full Text] [Related]
13. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
[TBL] [Abstract][Full Text] [Related]
14. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
15. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
16. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression.
Ishimura A; Minehata K; Terashima M; Kondoh G; Hara T; Suzuki T
Development; 2012 Feb; 139(4):749-59. PubMed ID: 22241836
[TBL] [Abstract][Full Text] [Related]
17. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
18. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
Choi WI; Yoon JH; Kim MY; Koh DI; Licht JD; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18641-56. PubMed ID: 24821728
[TBL] [Abstract][Full Text] [Related]
20. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
